Bio Saga Blog - A Chronicle of Life Sciences & Informatics

text mining, manual annotation, data alerts, pubmed, genes, drugs, processes, diseases, free, data mining, tag, drug discovery, web 2.0, natural language processing, data analysis, visualization, concept linking, abstraction, precision, recall, data accuracy, proteins, interactions, index, query, MeSH, NLM, manual curation, protein interactions, abstraction, abstracts, accuracy, accurate, data, annotations, biological process, biomedical literature, categorization, colloborations, concept linking, curate, curation, data accuracy, data alerts, literature, categorization, colloborations, concept linking curate curation data accuracy data alerts da, abstracts, annotations, biological process, categorization, colloborations, data accuracy, data analysis, data mining, drug discovery, MeSH, molecules, natural language processing, NLM, NLP, precision, processes, protein function, protein interactions, publishing, pubmed, query, rec...

Mayo Clinic is extending its brand across the country. This time, it is offering a free personal health record on the Microsoft HealthVault platform. The Mayo Clinical Health Manager , as the PHR is known, will provide not only a secure place to store medical records online, but also guidance from Mayo experts that will be tailored to the information contained in that PHR. If you are a 50-year-old man with diabetes and hypertension, for example, you will receive information about how you should take care of those conditions and the tests you should receive. Initially, Mayo Clinic Health Manager will include tools and features that help consumers manage pediatric and adult wellness, immunizations, pregnancy and asthma. Forthcoming features will help users with type 2 diabetes, high cholesterol, and/or high blood pressure. According to Mayo’s press kit , PHR users will be able to “transfer data directly into [a] Mayo Clinic Health Manager profile from a wide range of providers, devices...

Pharmaceutical companies are under constant pressure to develop new "blockbuster" drugs to replace older ones that are going off patent. With costs to launch a new drug crossing $1 billion and the number of drugs approved for commercial launch decreasing, pharmaceutical companies are increasingly looking at biotechnology to deliver results. Traditional "big pharma" companies currently account for about 65% of total R&D expenditure but they have a share of less than one third of drugs in the pipeline. On the other hand, smaller biotech companies account for 35% of total R&D spending with almost two thirds of the total drugs in pipeline. With bioinformatics increasingly becoming the backbone of drug research, the bioinformatics market is piggybacking on the investments made in drug discovery and development, and finds application in every stage of the pharmaceutical and biotech R&D process. The global bioinformatics market of about $2.3 billion is expected...

Bioinformatics companies XTractor Premium - A Platform for discovery , analysis and modelling of published biomedical facts. The only Knowledgebase which provides "manually" annotated facts from PubMed on a weekly basis Innovative Features like Semantic Search , Concept Linking , Bibliographic search , Save, Export and Visualize Only Knowledgebase with daily updations from PubMed XTractor Premium now at Introductory Offer of $450 for Academic Researchers. Subscribe now and save $300! Register for WebEx Request for a Trial